Cormorant Asset Management

What is Cormorant Asset Management?

Cormorant Asset Management, LP is an employee-owned hedge fund sponsor that has built a reputation in focusing on the healthcare and life sciences sectors.

Founded in 2013, Cormorant has dedicated its investment strategy to playing a pivotal role in the innovative and fast-growing realm of healthcare, with a particular emphasis on biotechnology, pharmaceuticals, medical devices, and diagnostics companies.

Their approach is characterized by deep diligence and a commitment to understanding the complexities inherent in the healthcare market.

They identify companies with strong growth potential, disruptive technologies, and the opportunity to provide meaningful clinical advancements. Cormorant invests in both public and private companies and offers the flexibility to engage in a variety of securities, from equity to debt.

Despite their potential to invest across a wide range of funding stages, Cormorant maintains a selective investment approach, as evidenced by both their maximum and minimum investment size of $90,000,000. This indicates a focus on substantial investments, likely in later-stage companies or significant financing rounds. As an active participant in the companies they invest in, Cormorant aims to add value beyond capital, leveraging their extensive network and expertise in the sector to champion the growth and success of their portfolio companies.

The seasoned team at Cormorant brings a wealth of knowledge and experience, driving the firm's research-intensive analysis and strategic investment selections.